(ARQ) Arq - Overview
Stock: Activated Carbon, Powder, Wetcake, Additives
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 67.4% |
| Relative Tail Risk | -14.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.51 |
| Alpha | -64.26 |
| Character TTM | |
|---|---|
| Beta | 1.351 |
| Beta Downside | 1.178 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.66% |
| CAGR/Max DD | 0.05 |
Description: ARQ Arq December 30, 2025
Arq, Inc. (NASDAQ: ARQ) is an environmental-technology firm that markets consumable treatment solutions for air, water and soil using activated carbon. Its product lineup includes granular and powdered activated carbon, colloidal carbon, a low-ash coal-waste derivative called Arq Powder Wetcake, and specialty additives for emissions control. These materials are deployed in water-treatment plants, groundwater remediation projects, soil-sediment cleanup, industrial air-emissions systems, and as performance enhancers in asphalt. The company, originally founded as Advanced Emissions Solutions in 1997, rebranded to Arq, Inc. in February 2024 and is headquartered in Greenwood Village, Colorado.
According to the most recent Form 10-K (FY 2023), ARQ generated roughly $63 million in revenue-a year-over-year increase of about 12%-and reported a gross margin near 45%, though these figures are pending final audit confirmation. The activated-carbon market is being propelled by stricter EPA regulations on volatile organic compounds (VOCs) and emerging contaminants such as PFAS, which together are expected to lift global demand for carbon-based adsorbents by 6-8% CAGR through 2030. Additionally, U.S. infrastructure legislation earmarks over $1 trillion for water and wastewater upgrades, creating a sizable tailwind for firms like ARQ that supply treatment media.
For a deeper quantitative comparison of ARQ’s valuation metrics against peers, the ValueRay platform offers a concise dashboard worth checking out.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -3.92m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.15 > 0.02 and ΔFCF/TA 0.60 > 1.0 |
| NWC/Revenue: 3.48% < 20% (prev 51.88%; Δ -48.40% < -1%) |
| CFO/TA 0.02 > 3% & CFO 5.24m > Net Income -3.92m |
| Net Debt (27.9m) to EBITDA (9.55m): 2.93 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.6m) vs 12m ago 11.12% < -2% |
| Gross Margin: 33.36% > 18% (prev 0.37%; Δ 3299 % > 0.5%) |
| Asset Turnover: 42.28% > 50% (prev 39.30%; Δ 2.98% > 0%) |
| Interest Coverage Ratio: -0.50 > 6 (EBITDA TTM 9.55m / Interest Expense TTM 2.74m) |
Altman Z'' 1.92
| A: 0.01 (Total Current Assets 43.9m - Total Current Liabilities 39.8m) / Total Assets 277.9m |
| B: 0.23 (Retained Earnings 63.9m / Total Assets 277.9m) |
| C: -0.00 (EBIT TTM -1.38m / Avg Total Assets 279.0m) |
| D: 1.05 (Book Value of Equity 63.9m / Total Liabilities 60.8m) |
| Altman-Z'' Score: 1.92 = BBB |
Beneish M -3.18
| DSRI: 0.81 (Receivables 14.4m/16.6m, Revenue 117.9m/110.0m) |
| GMI: 1.10 (GM 33.36% / 36.60%) |
| AQI: 0.84 (AQ_t 0.16 / AQ_t-1 0.19) |
| SGI: 1.07 (Revenue 117.9m / 110.0m) |
| TATA: -0.03 (NI -3.92m - CFO 5.24m) / TA 277.9m) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of ARQ shares?
Over the past week, the price has changed by -1.12%, over one month by -0.56%, over three months by -14.15% and over the past year by -43.86%.
Is ARQ a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ARQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.6 | 145.2% |
| Analysts Target Price | 8.6 | 145.2% |
| ValueRay Target Price | 3.5 | -1.7% |
ARQ Fundamental Data Overview February 03, 2026
P/S = 1.2887
P/B = 0.7176
Revenue TTM = 117.9m USD
EBIT TTM = -1.38m USD
EBITDA TTM = 9.55m USD
Long Term Debt = 8.80m USD (from longTermDebt, last quarter)
Short Term Debt = 19.6m USD (from shortTermDebt, last quarter)
Debt = 35.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 27.9m USD (from netDebt column, last quarter)
Enterprise Value = 179.9m USD (152.0m + Debt 35.0m - CCE 7.03m)
Interest Coverage Ratio = -0.50 (Ebit TTM -1.38m / Interest Expense TTM 2.74m)
EV/FCF = -4.40x (Enterprise Value 179.9m / FCF TTM -40.8m)
FCF Yield = -22.70% (FCF TTM -40.8m / Enterprise Value 179.9m)
FCF Margin = -34.63% (FCF TTM -40.8m / Revenue TTM 117.9m)
Net Margin = -3.33% (Net Income TTM -3.92m / Revenue TTM 117.9m)
Gross Margin = 33.36% ((Revenue TTM 117.9m - Cost of Revenue TTM 78.6m) / Revenue TTM)
Gross Margin QoQ = 28.82% (prev 33.30%)
Tobins Q-Ratio = 0.65 (Enterprise Value 179.9m / Total Assets 277.9m)
Interest Expense / Debt = 1.68% (Interest Expense 587.0k / Debt 35.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.09m (EBIT -1.38m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.10 (Total Current Assets 43.9m / Total Current Liabilities 39.8m)
Debt / Equity = 0.16 (Debt 35.0m / totalStockholderEquity, last quarter 217.2m)
Debt / EBITDA = 2.93 (Net Debt 27.9m / EBITDA 9.55m)
Debt / FCF = -0.68 (negative FCF - burning cash) (Net Debt 27.9m / FCF TTM -40.8m)
Total Stockholder Equity = 217.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.41% (Net Income -3.92m / Total Assets 277.9m)
RoE = -1.80% (Net Income TTM -3.92m / Total Stockholder Equity 217.3m)
RoCE = -0.61% (EBIT -1.38m / Capital Employed (Equity 217.3m + L.T.Debt 8.80m))
RoIC = -0.45% (negative operating profit) (NOPAT -1.09m / Invested Capital 243.9m)
WACC = 9.10% (E(152.0m)/V(187.0m) * Re(10.89%) + D(35.0m)/V(187.0m) * Rd(1.68%) * (1-Tc(0.21)))
Discount Rate = 10.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 12.37%
Fair Price DCF = unknown (Cash Flow -40.8m)
EPS Correlation: 53.17 | EPS CAGR: 12.15% | SUE: 0.79 | # QB: 0
Revenue Correlation: 32.18 | Revenue CAGR: 3.61% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.07 | Chg30d=-0.007 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.07 | Chg30d=-0.018 | Revisions Net=-1 | Growth EPS=+40.0% | Growth Revenue=+14.6%